ZR8 Stock Overview
A biopharmaceutical company, engages in the precision medicine business. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Oncodesign Precision Medicine Société anonyme Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €2.11 |
| 52 Week High | €2.11 |
| 52 Week Low | €0.94 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 322.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| ZR8 | DE Biotechs | DE Market | |
|---|---|---|---|
| 7D | 0% | 0.8% | -1.3% |
| 1Y | n/a | -17.5% | 7.4% |
Return vs Industry: Insufficient data to determine how ZR8 performed against the German Biotechs industry.
Return vs Market: Insufficient data to determine how ZR8 performed against the German Market.
Price Volatility
| ZR8 volatility | |
|---|---|
| ZR8 Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 6.4% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: ZR8 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ZR8's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | n/a | n/a | www.oncodesign.com |
Oncodesign Precision Medicine (OPM), a biopharmaceutical company, engages in the precision medicine business. It offers diagnostic and therapeutic solutions for resistant and metastatic cancers. The company is based in Dijon, France.
Oncodesign Precision Medicine Société anonyme Fundamentals Summary
| ZR8 fundamental statistics | |
|---|---|
| Market cap | €22.43m |
| Earnings (TTM) | €0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs ZR8 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ZR8 income statement (TTM) | |
|---|---|
| Revenue | €0 |
| Cost of Revenue | €0 |
| Gross Profit | €0 |
| Other Expenses | €0 |
| Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did ZR8 perform over the long term?
See historical performance and comparison